183 related articles for article (PubMed ID: 763270)
21. [Diabetic control with a portable insulin infusion pump for 7 weeks (author's transl)].
Irsigler K; Kritz H; Koller W; Kaspar L; Mader R; Franetzki M
Med Klin; 1978 Dec; 73(49):1738-43. PubMed ID: 723761
[TBL] [Abstract][Full Text] [Related]
22. A portable infusion pump, programmable with 16 rates.
Bojsen J; Kølendorf K; Haslev F; Jørgensen K
Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
[TBL] [Abstract][Full Text] [Related]
23. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
24. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
Stavljenić A; Granić M; Topić B; Skrabalo Z
Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
[TBL] [Abstract][Full Text] [Related]
25. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
27. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
[No Abstract] [Full Text] [Related]
28. Insulin infusion pumps in the treatment of diabetes.
Blackshear PJ
Med Instrum; 1982; 16(1):17-9. PubMed ID: 7038411
[TBL] [Abstract][Full Text] [Related]
29. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.
Tamborlane WV; Sherwin RS; Genel M; Felig P
Lancet; 1979 Jun; 1(8129):1258-61. PubMed ID: 87725
[TBL] [Abstract][Full Text] [Related]
30. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
Raskin P; Pietri A; Unger R
Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
[TBL] [Abstract][Full Text] [Related]
31. Portable insulin infusion systems in juvenile-onset diabetes.
Tamborlane WV
Hosp Pract; 1980 Oct; 15(10):91-9. PubMed ID: 6998857
[No Abstract] [Full Text] [Related]
32. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
[TBL] [Abstract][Full Text] [Related]
33. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
[TBL] [Abstract][Full Text] [Related]
34. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.
Gertner JM; Tamborlane WV; Horst RL; Sherwin RS; Felig P; Genel M
J Clin Endocrinol Metab; 1980 May; 50(5):862-6. PubMed ID: 6246134
[No Abstract] [Full Text] [Related]
35. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.
Lager I; Lönnroth P; von Schenck H; Smith U
Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1661-4. PubMed ID: 6416540
[TBL] [Abstract][Full Text] [Related]
36. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
[TBL] [Abstract][Full Text] [Related]
37. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
Pickup JC; Keen H; Parsons JA; Alberti KG
Br Med J; 1978 Jan; 1(6107):204-7. PubMed ID: 340000
[TBL] [Abstract][Full Text] [Related]
38. Long-term continuous subcutaneous insulin infusion in diabetics at home.
Pickup JC; White MC; Keen H; Parsons JA; Alberti KG
Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966
[TBL] [Abstract][Full Text] [Related]
39. Regulation of brittle diabetics by a pre-planned insulin infusion programme.
Deckert T; Lorup B
Diabetologia; 1976 Dec; 12(6):573-9. PubMed ID: 1001846
[TBL] [Abstract][Full Text] [Related]
40. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
